Document 0109
 DOCN  M9480109
 TI    Antibodies to pneumococcal capsular polysaccharides in children with
       human immunodeficiency virus infection given polyvalent pneumococcal
       vaccine.
 DT    9410
 AU    Arpadi SM; Back S; O'Brien J; Janoff EN; Bronx Lebanon Hospital Center,
       New York.
 SO    J Pediatr. 1994 Jul;125(1):77-9. Unique Identifier : AIDSLINE
       MED/94293134
 AB    Antibody to 7 common pneumococcal capsular polysaccharides was measured
       in 11 children with human immunodeficiency virus (HIV) infection who had
       been previously vaccinated with 23-valent polysaccharide pneumococcal
       vaccine, 11 unvaccinated children with HIV infection, and 11 healthy
       subjects. No differences in capsule-specific IgG levels against
       serotypes 4, 6B, 8, 12F, 14, 19A, and 19F were observed among the
       vaccinees with HIV infection compared with unvaccinated children with
       HIV infection and age-matched control children.
 DE    Antibodies, Bacterial/*BLOOD  Bacterial Vaccines/*IMMUNOLOGY
       Case-Control Studies  Child  Child, Preschool  Female  Human  HIV
       Infections/*IMMUNOLOGY  IgG/*BLOOD  Male  Polysaccharides,
       Bacterial/*IMMUNOLOGY  Streptococcus pneumoniae/*IMMUNOLOGY  Support,
       U.S. Gov't, Non-P.H.S.  Support, U.S. Gov't, P.H.S.  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).